Navigation Links
Georgetown Lombardi Comprehensive Cancer Center Taps Ariadne for G-DOC Pathway Data and Tools

ROCKVILLE, Md., Feb. 10, 2011 /PRNewswire/ -- Ariadne, a leader in bioinformatics software and knowledge integration, announces today that Georgetown University signed a site license for the use of Pathway Studio® software.  In continuing its goal of adopting and applying innovative technologies, Georgetown Lombardi Comprehensive Cancer Center will employ Pathway Studio to aid researchers in their efforts to unravel cancer disease biology, disease progression, and translational medicine.  These research findings will be shared using Pathway Studio through the Georgetown Database of Cancer (G-DOC) initiative.

"Translational medicine has become increasingly important as an investigative tool to help identify biomarkers and surrogate markers involved with disease or therapeutic response.  Finding tools that can help integrate published findings with our microRNA experimental data is exciting as this advancement will enhance our ability to create disease models and hypotheses more rapidly and with greater accuracy," states Dr. Subha Madhavan, Director of Clinical Research Informatics at Georgetown Lombardi.

"Ariadne's expertise in developing biological knowledgebases for disease modeling fits nicely into Georgetown Lombardi's vision and goals.  We look to help them achieve greater understanding of cancer and to apply these discoveries to have the greatest impact in translational medicine," states Ilya Mazo, president of Ariadne.

Pathway Studio's workflow approach allows researchers to mine, integrate, analyze and visualize results individually or as an integrated workflow.  Each step can be saved, then updated or modified as new information becomes available. Separate analyses can be combined or intersected for advanced applications and discovery.  

For more information about Pathway Studio and Ariadne, visit the Ariadne website at, or call 240-453-6296, or email us at

About Ariadne Ariadne (, a leader in research data products and knowledge enrichment-based software solutions, helps pharmaceutical and life science researchers tap known scientific knowledge for applications in systems biology and translational medicine. We provide a portfolio of solutions for life science, drug discovery and development applications including custom data products, knowledge extraction and visualization software, knowledge reports, and informatics staffing.

Pathway Studio, built and powered by MedScan® technology, is integrated data mining and visualization software that allows organizations and researchers to rapidly extract relevant facts and relationships from large document collections (text-mining), build focused knowledgebases (databases), while supporting the integration of OMICS experiments. The extracted knowledge is used in an interactive scaffold for defining and testing in silico-based hypotheses across a wide range of disciplines including mechanistic modelling of disease, drug action and toxicity, as well as biomarker discovery, cellular and network pathway building, protein-protein interactions and many more.

Pathway Studio is available in desktop and enterprise versions along with therapeutic-focused knowledgebases and cartridges. For more information, visit us at

About Georgetown Lombardi Comprehensive Cancer CenterGeorgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 40 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to Contact:David DennyDirector of Marketing, AriadneEmail: Tel: 240-453-6296

SOURCE Ariadne
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Amphotericin B - Comprehensive patent search
2. Silence Therapeutics Receives Comprehensive Protection for RNAi Structural Modification Technology in Single European Patent
3. Terrorist de-radicalization shows promise, comprehensive study finds
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. Three Nephrology TreatmentTrends Publications from BioTrends Provide a Comprehensive View of Bone and Mineral Metabolism Practice Patterns Around the Globe
6. Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos
7. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
8. The Medical College of Wisconsin Adopts Quantros Event Manager(TM) and Claims Manager(TM) for Comprehensive Malpractice Litigation Management
9. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting
10. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
11. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
Post Your Comments:
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):